Chapter 10: Diseases of Infancy and Childhood

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today, we are tackling a subject that is

honestly, simultaneously incredibly delicate, heartbreaking,

and just scientifically fascinating.

It really is.

It's a heavy one today.

Yeah, it is.

We are opening up chapter 10 of Robbins, Cotran, and Kumar Pathologic Basis of Disease, and we are strictly focusing on the diseases of infancy and childhood.

Right.

And it's, I mean, it deals with the most vulnerable patients in medicine, right?

But it's also probably one of the most critical chapters for a student of pathology because it establishes a really fundamental rule right out of the gate.

Which is that children are not just little adults.

Exactly.

Children are not just little adults.

You can't just shrink things down.

Right.

You can't just take an adult disease, shrink the parameters down and apply it to a specialized tiny human.

Their physiology,

their, well, their developmental stage and the way their bodies react to injury are fundamentally unique.

And that's essentially the bumper sticker for this entire deep dive for you listening.

We are at diseases that often just, they don't exist in the adult world, or if they do exist, they take on completely distinctive forms.

I mean, we are dealing with congenital anomalies, the physiological struggles of prematurity and tumors that honestly, they look more like embryonic tissue than the thinkable cancers we see in adults.

So the mission for this deep dive is to navigate this landscape sequentially, literally just as Robbins lays it out for you.

We are going to translate this really dense medical text into a clear, logical narrative.

Yeah.

Starting with the big picture, the stakes, the epidemiology.

Right.

And then moving through congenital anomalies, prematurity, infections, and finally those really specific tumors you mentioned.

And we really should start with that epidemiology because it sets the stage for why this matters so much to you as a clinician or a student.

Okay.

So the text highlights a really interesting and largely positive trend in infant mortality.

If you look at the United States, the rate dropped significantly from 1970 to 2021.

A huge drop.

Yeah.

We went from 20 deaths per 1000 live births down to 5 .4.

That is a massive improvement.

It is.

And it's a testament to advances in neonatal care.

We have better ventilators now, better drugs like surfactant, which we'll get into, and far better prenatal monitoring.

But Robbins also points out a pretty concerning reversal, right?

During the COVID -19 pandemic, that rate actually began to rise again.

Yeah.

Which just shows how fragile these medical gains can be when the entire healthcare system is stressed.

And when you look deeper into those numbers,

the disparities are stark.

The text explicitly calls out the gap between African American and white American infant mortality rates.

It does.

It's a critical data point.

African Americans continue to have an infant mortality rate of 11 deaths per 1000 live births.

Which is more than twice the rate of white Americans, which sits at around 4 .9.

Correct.

That is a hard epidemiological fact that reflects deep systemic issues.

And if we zoom out to an international context, the United States ranks 30th among developed nations.

30.

Yeah.

We are looking at countries like Slovenia with a rate as low as 1 .8.

So while we have made progress, the US standing suggests there is still significant work to be done compared to our peers.

Now, when we talk about childhood diseases, we aren't talking about one big uniform bucket.

The risks change dramatically as a child grows.

The text breaks this down into four distinct developmental stages.

It does.

You have the neonatal period, which is just the first four weeks of life.

This is the absolute highest risk window.

Right.

Then infancy, which covers the rest of the first year.

Then early childhood, which is one to four years.

And finally, later childhood ages five to 14.

So walk us through how the risks evolve through those specific stages.

Well, in that first year, so the neonatal period and infancy, the leading causes of death are almost entirely biological and developmental.

We're talking about things going wrong internally.

Exactly.

Congenital anomalies, disorders related to short gestation, meaning prematurity and low birth weight and sudden infant death syndrome or SIDs.

So in the beginning, it's really about surviving that initial transition from the womb to the outside world.

It's about whether the structural machine was built correctly and if it can sustain itself.

That's a great way to put it.

But once an infant survives that first year, the outlook brightens considerably.

The causes of death shift away from internal biology to external risks.

Like accidents.

Right.

In children aged one to nine, the absolute leading cause becomes unintentional injuries, accidents,

congenital anomalies and malignant neoplasm.

So cancer follow that, but accidents take the top spot by far.

And then as they get older into that 10 to 14 bracket.

By the time you hit the 10 to 14 age group, accidents are still at the top, followed by malignancies.

But tragically, you start seeing suicide and homicide entering the list of leading causes.

The environment changes.

It completely shifts from biological failure to societal and psychological challenges.

That is a very sobering trajectory to keep in mind.

But let's go back to that first major hurdle,

congenital anomalies.

I want to define our terms here because congenital is a word we hear a lot, but I'm not sure everyone listening knows exactly what it implies medically.

The simplest definition is that congenital just means born with.

That is it.

It doesn't mean genetic.

No, it does not necessarily mean it has a genetic basis.

It just means the defect is present at the exact time of birth.

It could be caused by a virus, a drug, a mechanical force in the uterus or a gene.

Okay.

So born with is the broad umbrella, but Robbins breaks this down into three very specific

malformations, disruptions and deformations.

And these are definitely not synonyms.

They are definitely not.

And understanding the difference is crucial for you to understand the actual cause of the pathology.

Let's start with malformations.

This is an intrinsic error of morphogenesis.

Meaning the developmental process itself is wrong.

Exactly.

The blueprint itself or the biological execution of that blueprint was flawed from the very start.

The tissue didn't form right because the instructions were bad.

So something like a cleft lip or a congenital heart defect.

Precisely.

And the text provides a great visual figure 10 .1 of an infant with a cleft lip to illustrate this.

The facial tissue didn't fuse correctly because the genetic or signaling instructions during organogenesis were wrong.

And Robbins notes this is often multifactorial, right?

Yes.

Meaning a complex mix of genetics and environmental influences.

But the key is the error happened during the actual formation of the structure.

Okay.

That's malformation.

A bad blueprint.

How is that functionally different from a disruption?

A disruption is a secondary destruction of an organ or a body region that was previously totally normal.

So it was fine.

And then something happened.

Right.

The organ was forming correctly.

The blueprint was fine.

But then an extrinsic disturbance came in and wrecked it.

The classic example the book uses here is amniotic bands.

Yes.

Imagine the amnion, which is the inner sac surrounding the fetus.

If it ruptures early, it forms these fibrous strands or bands that just float around in the amniotic fluid.

Like loose strings.

Exactly.

And these bands can encircle a developing limb or a digit of the fetus.

As the fetus grows, that band doesn't.

So it creates a constriction, literally like a tourniquet.

The text mentions figure 10 .2 here, which shows an amniotic band literally constricting a fetal leg.

It is a pure mechanical interference.

The key takeaway for disruptions for your exams is that they are not heritable.

Because it's an accident of the pregnancy environment, it doesn't increase the risk for the parent's next pregnancy at all.

It's like a storm damaging a well -built house.

Perfect analogy.

That brings us to the third category,

deformations.

Deformations are also extrinsic, like disruptions, but they are caused by abnormal biomechanical forces, usually compression.

So molding the fetus into the wrong shape.

Exactly.

And the main culprit here is the uterine constraint.

Because between 35 and 38 weeks, the fetus is growing so rapidly, it's outpacing the uterus.

Right.

So if you have a structurally small uterus or multiple fetuses like twins or low amniotic fluid, which is oligohydrominoes, the fetus just gets squashed.

And that leads to things like club feet.

Yes.

The foot developed normally, structurally speaking.

The bones and joints are all there.

But it was twisted into an abnormal fixed position by prolonged physical pressure.

So just to recap for you listening,

malformation is a bad blueprint.

Disruption is a storm damaging the house.

Deformation is the room being too small for the furniture.

That is exactly how you should conceptualize it.

Now we need to clarify another major distinction, the difference between a sequence and a syndrome.

Because in casual medical conversation, people swap these constantly, but pathologically, they describe very different chains of events.

Very distinct.

A sequence is a cascade.

You have one single initiating event, one domino falls, and it naturally knocks down a whole predictable line of other dominoes.

The deep dive example Robbins gives here is the oligohydrominoes sequence, also known as Potter sequence.

Let's visualize figure 10 .3 and 10 .4.

Let's unpack that cascade.

The initiating event, the first domino, is oligohydrominoes, decreased amniotic fluid.

What causes that?

It could be a chronic leak of amniotic fluid from the mother,

or very commonly the fetus has a renal issue, like bilateral renaligenesis.

If the fetus has no kidneys, it isn't producing urine.

And fetal urine makes up most of the amniotic fluid in later pregnancy.

Exactly.

So no fluid.

What is the cascade?

Without that fluid cushion, the uterus severely compresses the fetus.

This causes flattened facial features and positional defects like club feet.

Which are deformations.

But the truly lethal part of the sequence is that amniotic fluid is physically required for lung development.

The fetus normally breathes the fluid in and out to stretch and expand the developing lungs.

So without the fluid, you get pulmonary hypoplasia, severely underdeveloped lungs.

So the baby is born with club feet and a flat face, but tragically dies because the lungs didn't form.

All triggered by the single initiating event of low fluid.

That is a sequence.

Correct.

Contrast that with a syndrome.

A syndrome is a constellation of anomalies that are pathologically related, usually by a single etiologic agent.

Like a viral infection or a chromosomal abnormality.

Yes.

But instead of a domino effect, that single agent affects multiple different tissues simultaneously and independently.

So in a syndrome, the heart defect didn't cause the facial defect.

They were both caused by the exact same bad gene or virus at the exact same time.

Exactly.

A sequence is a domino effect.

A syndrome is a shotgun blast.

Before we move on to the actual causes of anomalies, the text lists some really high yield organ specific terminology.

I'm going to throw them at you for a rapid fire definition because these show up in pathology reports constantly.

Let's do it.

First one, agenesis.

Complete absence of an organ and its primordium and never even started forming.

For example, renal agenesis, no kidney formed at all.

Aplasia.

The organ failed to develop normally.

It might be entirely missing, but the key distinction is implies there was a rudimentary structure or a primordium present that just failed to grow.

Atresia.

Absence of an opening.

Think of a biological tube that should be hollow, but is solid or closed off, like esophageal atresia or biliary atresia.

Hypoplasia versus hyperplasia.

This is strictly about cell number.

Hypoplasia means too few cells, so the organ is small and functionally underdeveloped.

Hydroplasia is an increased cell number, so the organ is larger than normal.

What about hypertrophy and hypertrophy?

That is about cell size, not number.

The number of cells is normal, but each individual cell is too big or too small.

And finally, dysplasia.

Now, in the context of congenital malformations, this means abnormal organization of cells.

The cells are present, but they are scrambled.

The tissue architecture is fundamentally disordered.

Okay, definition's established.

Let's talk about causes.

We know it's a mix of genetic, environmental, and multifactorial, but Robbins zooms in on the specific signaling pathways because this is where the science gets really granular.

This is where we see just how fragile early development really is.

The text highlights the hedgehog signaling pathway.

Which is a genuinely great name for a biological pathway.

It is.

Sonic hedgehog is the most famous one.

But if you have a loss of function mutation in the hedgehog pathway, the result is devastating.

It causes holoprosencephaly.

Break that down for us.

The embryonic forebrain normally divides into two distinct hemispheres.

In holoprosencephaly, it fails to separate.

You essentially have a single lobed brain.

It creates a severe cyclopea -like facial appearance in the most extreme cases.

And the text connects this to a very specific environmental trigger too, right?

Valproic acid.

Yes.

Valproic acid is a common anti -seizure medication.

If a pregnant woman takes it, it disturbs the expression of HOX proteins.

HOX genes are the master architects.

They are the master body plan genes.

They literally tell the embryo where it put the arms, the legs, the head.

Disturbance of HOX expression by Valproic acid can lead to limb, vertebral, and severe craniofacial defects.

It's a prime example of a chemical drug interfering directly with a genetic signaling pathway.

Exactly.

Speaking of drugs and environmental triggers, let's talk to adagins.

The text lists some of the historical and modern heavy hitters.

We absolutely have to mention thalidomide.

It is the tragic foundational history lesson of teratology.

Back in the mid -20th century, it was widely used in Europe as a tranquilizer and a remedy for morning sickness.

And it caused horrific limb malformations.

Specifically, amelia, which is the total absence of limbs, or meramelia, which results in short flipper -like limbs.

It essentially showed the medical world that the placenta is not an impenetrable,

It changed pharmacology forever.

Then there is retinoic acid, or isotretinoin.

And this one is incredibly potent as a peratogen.

It causes profound CNS, cardiac, and cleft palate defects.

The mechanism is fascinating because retinoic acid is actually a natural morphogen in the body, but giving it artificially disrupts TGF beta signaling, which is normally required for forming the palate and the heart.

Of course, the text covers alcohol.

Fetal alcohol syndrome.

It remains one of the major causes of acquired intellectual disability.

You see severe growth restriction, microcephaly, meaning a small head and brain, and very distinct facial anomalies like maxillary hypoplasia.

What about maternal infections?

Viral teratogens are huge.

The rubella virus causes the classic rubella triad.

Cataracts, deafness, and heart defects.

But only if the mother is infected during the critical early weeks of pregnancy.

Zika virus is mentioned too.

Yes, Zika gained global attention for causing severe microcephaly by directly targeting the developing neural progenitor cells in the fetal brain.

The text also emphasizes maternal diabetes, diabetic embryopathy.

Right.

If a mother has poorly controlled diabetes, the hyperglycemia crosses the placenta.

The fetus responds by releasing tons of its own insulin.

This hyperinsulinemia leads to fetal macrosomia.

A very large baby.

Yes, large body size.

But it also increases the risk of specific cardiac anomalies and neural tube defects.

And all of this circles back to the concept that timing is everything.

Figure 10 .5 shows a detailed timeline of susceptibility.

This is a crucial concept for you to grasp.

The critical period.

The embryonic period, which is weeks one through nine, is the extreme high -risk zone.

But it's broken down even further.

It is.

Weeks three through nine are when organogenesis happens.

That's the actual building of the organs from germ layers.

This is the window of maximum susceptibility to teratogens, causing gross structural malformations.

What about before week three, the very first days?

Weeks one to three are considered the all -or -none period.

If a toxic insult happens here, either the embryo dies, resulting in a spontaneous abortion, or the cells are able to compensate and recover completely because they are still titipatent.

So there's usually no middle ground of a malformation that early on.

And after week nine, once we enter the fetal period.

By week nine, the organs are basically formed.

They are small, but the architecture is there.

The fetal period primarily involves growth and tissue maturation.

So the susceptibility to major structural malformations drastically decreases.

But they aren't totally safe.

No, you can still get physiologic defects, functional abnormalities in the brain, or significant growth restriction.

That segues perfectly into our next major topic from the chapter.

Prematurity and fetal growth restriction.

These are two very different clinical entities, even though they often overlap in the NICU.

Prematurity is defined strictly by the calendar.

It is a gestational age of less than 37 weeks, period.

And the risk factors for prematurity are things like preterm premature rupture of membranes, or PP -ROM, or an introadherent infection, like chorionitis, or even structural issues with the uterus or placenta, like placenta previa.

Right, or multiple gestations like twins or triplets stretching the uterus too much.

But then you have fetal growth restriction, or FGR.

These are infants who are considered small for gestational age, or SGA.

Yes, they might be born at full term, or they might be early, but regardless of when they are born, they are smaller than they statistically should be for their specific developmental age.

And Robbins categorizes the causes of fetal growth restriction into three distinct buckets.

Fetal, placental, and maternal.

This distinction fundamentally matters for the clinical outcome.

Let's say the cause is fetal.

This means a chromosomal disorder, or a torish infection that the fetus contracted.

In these cases, the growth restriction is usually symmetric.

Meaning the whole baby is proportionally small.

Exactly.

The body is small, the organs are small, and the head is small.

The intrinsic late potential was reduced from the start.

Because the problem is built into the baby's own cellular machinery, or caused by an early systemic infection.

Right.

But if the cause is placental, like utero -placental insufficiency, where the blood flow is compromised, the growth restriction is often asymmetric.

Explain asymmetric in this context.

The body is small and underdeveloped, but the brain is spared.

The head looks relatively normal size compared to the tiny skinny body.

Why does the body do that?

It is a remarkable survival mechanism.

The fetus senses the chronic lack of nutrients and oxygen coming from the failing placenta, and it reflexively shunts blood away from the body, the gut, the kidneys, and directs it straight to the brain.

It prioritizes the brain above all else.

It does.

It sacrifices body fat and muscle to keep the brain developing.

That is incredible biology.

But regardless of the specific type, FGR puts the infant at severe risk for cerebral dysfunction,

temperature instability, and learning disabilities later in life.

Yes.

Now for the premature infant, one of the biggest, most immediate life -threatening hurdles is literally just breathing.

Neonatal respiratory distress syndrome, or NRDS.

Also classically known as hyaline membrane disease, this is entirely a disease of immaturity, specifically the immaturity of the lungs ability to produce enough surfactant.

Let's break down the mechanism here, because this is high yield.

Surfactant is essentially like a biological detergent, right?

That's exactly how it acts.

It is a lipid -rich fluid primarily made of dipalmatoil phosphatidylcholine, or lecithin.

It lines the alveoli, the tiny air sacs, and reduces surface tension.

Why is surface tension bad in the lung?

Imagine trying to blow up a completely wet balloon.

The water tension on the inside walls holds the rubber tightly shut.

It takes massive pressure to get that first breath of air in.

Surfactant breaks that tension.

So without surfactant, every time the premature baby exhales, the alveoli collapse completely flat.

They stick together.

This is called atelectasis.

And because they collapse, every single breath the baby takes is like blowing up a brand new wet balloon all over again.

And that takes immense physical effort for a tiny preemie.

They tire out incredibly fast.

The baby becomes deeply hypoxic.

And here is where the pathology loop starts.

This severe hypoxia and the physical shear stress of the lung tissue, constantly collapsing and ripping open, damages the delicate epithelial lining of the alveoli.

And when tissue is damaged, it leaks.

It leaks protein -rich fluid from the capillary straight into the alveolar spaces.

And that fluid hardens into the namesake of the disease, the highline membrane.

Right.

If you look at the histology in figure 10 .7, you see these thick pink eosinophilic layers completely lining the inside of the airways.

That is the highline membrane.

And it's basically a scab inside the lung.

It's made of necrotic epithelial cells and plasma proteins like fibrin.

It essentially creates a physical barrier that completely blocks whatever little gas exchange was still happening.

The text describes the gross morphology of these lungs at autopsy as heavy, purple, and they literally sink in water because they are entirely airless.

And clinically, if you look at a chest x -ray of a baby with NRDS, you see the classic round glass appearance.

It looks like a fine reticula granular density across both lung fields.

We have medical treatments now.

We give corticosteroids to the mother before birth to speed up the baby's lung maturation.

And we administer exogenous surfactant therapy directly down the baby's trachea.

But the treatments themselves historically used to cause major secondary problems, didn't they?

They did.

And severe complications still occur.

This brings us to two major iatrogenic diseases of prematurity.

Retinopathy of prematurity, or ROP, and bronchopulmonary dysplasia, or BPD.

Let's start with ROP.

It's a story of oxygen toxicity.

It is.

Explain that mechanism, because it seems completely counterintuitive that giving a hypoxic baby life -saving oxygen causes them to go blind.

It's all about how the body senses oxygen.

In the premature eye, the retinal blood vessels are still actively growing out from the optic nerve toward the periphery.

Because they aren't fully formed until full term.

Right.

Now, if you blast that premature baby with high concentrations of therapeutic oxygen, causing hyperoxy in the blood, the local levels of VEGF drop dramatically.

Vascular endothelial growth factor.

Yes.

The eye says, hey, we have plenty of oxygen.

We don't need to build any more blood vessels.

So the normal vessel growth stops, or the existing vessels even regress.

Okay, so the vessels stop growing.

But how does that cause blindness later?

Because eventually, the baby's lungs improve, and you take them off the high oxygen and return them to normal room air.

Relative to what they were just getting, normal room air suddenly feels like profound hypoxia to that retina.

Oh, wow.

So the tissue panics.

Exactly.

The VEGF levels aggressively rebound and skyrocket.

This sudden massive surge causes a chaotic proliferation of new, completely abnormal vessels.

This is neovascularization.

And these new vessels aren't built right.

They are fragile, they bleed easily into the eye, and most importantly, they create fibrous scar tissue.

That scar tissue contracts and physically pulls on the retina, eventually causing retinal detachment and blindness.

It is the rebound effect that actually causes the structural damage.

That is a terrifying mechanism.

And what about bronchopulmonary dysplasia?

BPD is chronic damage to the lung architecture itself.

You have a fragile premature lung, and you subject it to the positive pressure of mechanical ventilation and high concentrations of oxygen.

Both of those cause massive influxes of inflammatory cytokines.

And how does that alter the lung development?

The primary result is a severe decrease in alveolar septation.

Instead of forming millions of tiny complex alveoli, the lung development is arrested.

You get large, overly simplified alveolar structures.

It's like building a house with a few massive rooms instead of many small rooms.

Perfect analogy.

And because gas exchange happens on the walls of those rooms, you lose a massive amount of surface area.

The lungs are structurally inefficient for life.

Moving down from the lungs to the gut, we encounter another truly terrifying condition in the NICU.

Necrotizing Enterocolitis, or NEC.

NEC is arguably one of the most feared complications in a premature infant.

It typically hits very low birth weight infants precisely when they have started enteral feeding, meaning they've started digesting actual formula or breast milk.

Why does feeding trigger an necrotic event in the bowel?

The pathogenesis is highly multifactorial.

You start with a premature, highly immature gut mucosal barrier.

Then normal colonizing bacteria are introduced from the environment.

And finally, you introduce a food substrate.

So it's a perfect storm.

Somewhere in that interaction, excessive inflammatory mediators, especially PAF, or platelet activating factor, start breaking down that already weak mucosal barrier.

And once that barrier is physically broken, the bacteria migrate directly into the wall of the intestine.

They start flourishing inside the tissue, triggering massive inflammation, ischemia, and ultimately coagulative necrosis.

The tissue dies.

And the absolute hallmark clinical sign here is something you can visualize on an X -ray.

Pneumatosis intestinalis.

Yes,

sub -mucosal gas bubbles.

The invading bacteria are literally producing gas inside the wall of the bowel.

You can see it on a plain film X -ray.

Grossly, if you are looking at figure 10 .8, the bowel looks severely distended, friable, and often dark red or gangrenous, usually affecting the terminal ileum and the cecum.

And if it progresses, the necrotic bowel can perforate, spilling feces into the abdomen, leading to overwhelming sepsis and shock.

Speaking of sepsis and bacteria, we really need to cover perinatal infections.

The text divides these into two primary routes of entry for the infant.

Transcervical, which is ascending, and transplacental, which is hematologic.

Let's take transcervical first.

Ascending infections happen when the baby either inhales infected amniotic fluid before birth, or picks up the pathogen while physically passing through an infected birth canal.

And this is usually bacterial.

Almost always.

The heavy hitters are Group B striptococcus, E.

coli, and sometimes herpes simplex virus if there are active lesions.

And these ascending infections typically lead to pneumonia or early onset sepsis, meaning symptoms appear within the first few days of life.

Right.

Now, transplacental infections are different.

These are hematologic.

The mother gets an infection, it enters her bloodstream, crosses the placental barrier, and infects the fetus during gestation.

This is the classic Tor -H complex.

Toxoplasma, others like syphilis and parvovirus, rubella, cytomegalovirus, and herpes.

The text calls out parvovirus B19 specifically here, because its pathology is so unique.

Parvovirus is fascinating because it has a singular, highly specific cellular target, the erythroid progenitors.

It selectively infects and destroys the baby's red blood cell precursors inside the fetal bone marrow.

And visually under the microscope, this creates a very distinct viral inclusion cell, doesn't it?

It does.

Figure 10 .9 shows the classic lantern cell appearance.

It is a giant pronormoblast with a massive glassy viral inclusion in the nucleus that pushes the chromatin to the edges.

And because the virus is literally destroying the red blood cell factories, the fetus develops severe aplastic anemia.

Exactly, which often leads directly to high drops fetalis.

Let's define that because it's a major topic.

Fetal high drops.

Fetal high drops is essentially generalized.

Massive edema in the fetus, lethal fluid accumulation in the tissues, and body cavities during gestation.

Historically, it used to be mostly caused by Rh incompatibility, immune high drops.

Right.

This is a classic devastating immunological battle.

It happens when you have an Rh negative mother carrying an Rh positive fetus.

The mother doesn't have the D antigen, but the baby does, inheriting it from the father.

Exactly.

Now, in the first pregnancy, the mother's immune system gets exposed to the fetal blood, usually during delivery.

She gets sensitized.

She recognizes the Rh antigen as foreign and makes antibodies against it.

But the first baby is usually totally fine.

Because those initial antibodies she makes are IgM class.

And IgM is a massive pentamer molecule.

It is simply too big to physically cross the placenta.

But the mother's immune system remembers.

It has memory B cells now.

So fast forward to a second pregnancy with another Rh positive fetus.

The mother's immune system immediately recognizes the antigen and produces a massive IgG response.

And IgG is small enough to cross the placenta.

It crosses easily.

Those maternal antibodies enter the fetal circulation, attached to the fetal red blood cells, and the fetal spleen completely destroys them.

Massive hemolysis.

So the fetus becomes profoundly anemic.

Yes.

And to desperately try and compensate for the anemia, the fetus tries to manufacture new blood cells everywhere it can.

The liver, the spleen, the kidneys.

This is called extramedullary hematopoiesis.

But it's not enough.

No.

The liver swells up and fails.

Protein production drops, which ruins oncotic pressure.

The severe anemia causes the fetal heart to work too hard and fail.

The combination of heart failure and low protein causes the baby to swell up with massive amounts of fluid.

High drops.

And there's a neurological component too.

Yeah.

Because the massive breakdown of all those red blood cells produces huge amounts of bilirubin.

Which leads to conicturus.

The fetal liver is too immature to conjugate all that bilirubin.

Unconjugated bilirubin is highly lipid soluble, so it easily crosses the developing blood -brain barrier.

And it deposits directly in the brain tissue.

Specifically in the basal ganglia and the thalamus.

If you look at figure 10 .13, it shows this vividly on autopsy.

The brain tissue in those areas has stained a bright toxic yellow.

It causes severe permanent neurologic damage if the infant survives.

Thankfully, this entire mechanism is rare now because we have Rogan.

Anti -D immunoglobulin.

We give it to the Rh negative mother at 28 weeks and right after birth.

It basically masks any fetal red cells that enter her circulation so her immune system never sees them.

She never gets sensitized.

It is one of the greatest triumphs of modern preventative medicine.

So because of Rogan, today most cases of high drops are nonimmune high drops.

Right.

We see generalized edema caused by other factors.

Severe structural cardiovascular defects that cause heart failure.

Or chromosomal anomalies like Turner syndrome, which is 45X.

Turner syndrome is classically associated with cystic hygroma, right?

Yes.

Large fluid accumulations in the neck due to abnormal lymphatic drainage.

And of course, severe fetal anemias from other causes like homozygous alpha thalassemia or the parvovirus B19 infection we just discussed can also cause nonimmune high drops.

Let's shift gears entirely and look at inherited metabolic disorders.

These are the classic inborn errors of metabolism.

Robbins highlights three major ones PKU, galactosemia,

and cystic fibrosis.

Let's start with PKU, phenylketonuria.

This is an autosomal recessive disorder caused by a severe deficiency in the liver enzyme phenylalanine hydroxylase or PAH.

And what does PAH normally do?

It converts the amino acid phenylalanine into tyrosine.

Without the enzyme, you can't break down phenylalanine from your diet.

It builds up in the blood to incredibly toxic levels and poisons the developing brain.

The classic clinical sign you read about for boards is the musty or mousy odor of the infant.

Yes, from the phenylacetic acid excreted in the sweat and urine.

You also see hypopigmentation.

These kids often have very fair hair and skin because remember, tyrosine is the precursor for melanin.

If you can't make tyrosine, you can't make melanin.

If it goes untreated, it causes severe irreversible intellectual disability and seizures.

But the treatment is conceptually very simple.

Dietary restriction.

You severely restrict phenylalanine intake early in life.

No meat, no dairy, no nuts.

And the brain develops normally.

We screen every newborn for this at birth.

Next is galactosemia.

Also, autosomal recessive.

This is a deficiency in the GALT enzyme, galactose -1 -phosphate -uradil -transferase.

Because of this, toxic metabolites like galactose -1 -phosphate accumulate in tissues.

Where does it do the most damage?

It heavily damages the liver, causing massive hepatomegaline jaundice.

It damages the brain, and very classically, it damages the eyes.

The metabolites accumulate in the lens, draw in water, and cause early cataracts.

O -pacification of the lens.

And the text includes a very specific clinical pearl here about infections.

Yes.

Infants with galactosemia are highly prone to fulminant E.

coli sepsis.

It's a very specific board -relevant association.

The treatment, again, is dietary.

Completely remove galactose and lactose, meaning all milk products, from the diet.

And finally, the big one in this category, cystic fibrosis, mucoviscidosis.

This is the most common lethal genetic disease in Caucasian populations.

Around 1 in 3 ,200 live births.

It is caused by mutations in the CFTR gene.

Which codes for a chloride channel.

Exactly.

The cystic fibrosis transmembrane conductance regulator.

The most common specific mutation is a deletion of three nucleotides coding for at position 508.

The delta 508 mutation.

So the chloride channel is fundamentally defective or degraded before it reaches the membrane.

Right.

And the resulting mechanism is entirely about the osmotic movement of salt and water.

But it behaves differently depending on the tissue.

Let's look at the sweat glands first.

Okay.

In the sweat glands.

Normally, as sweat moves to the surface, the CFTR channel reabsorbs chloride back into the body, and sodium follows it.

In CF, chloride cannot be reabsorbed.

It stays in the sweat duct.

Sodium stays with it.

Which leads to the classic salty baby syndrome.

Parents notice the baby tastes salty when they kiss them.

Exactly.

The sweat is hypertonic.

But in the respiratory and intestinal tracts, the problem is reversed.

How so?

In the lungs, the normal job of CFTR is to actively pump chloride out of the cell and into the airway fluid.

In CF, chloride can't get out.

So it builds up inside the cell.

And because of osmotic forces, sodium and water actively rush from the airway lumen into the cell to balance it.

So the airway surface liquid is severely dehydrated.

And the mucus that sits on top of that liquid becomes incredibly thick, dehydrated, and sticky.

Like glue.

And that viscous mucus mechanically obstructs everything.

In the lungs, it blocks airways, causing hyperinflation and ultimately bronchiactasis.

And it becomes a breeding ground for bacteria.

The sticky mucus traps bacteria, and the cilia can't clear it.

These patients suffer relentless chronic pulmonary infections, specifically with pathogens like Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia sepacea.

What about the pancreas?

How does the thick mucus affect digestion?

Same mechanical problem.

It creates viscous plugs in the pancreatic exocrine ducts.

The digestive enzymes are trapped inside the pancreas.

They start autodigesting the tissue.

The pancreas eventually undergoes complete atrophy and severe fibrosis.

If the enzymes can't reach the gut, you get massive malabsorption.

Yes.

Severe fat malabsorption.

This leads to large, greasy, foul -smelling stools and critical deficiencies in the fat -soluble vitamins, vitamin A, D, E, and K.

And it can cause problems immediately at birth in the intestine itself.

Meconium ileus.

The newborn's very first stool, the meconium, is normally thick, but in CF it is so viscid and dehydrated that it acts like a cement plug.

It physically blocks the small bowel, causing an intestinal obstruction right after birth.

It even fundamentally affects the reproductive system.

Yes.

Approximately 95 % of adult males with cystic fibrosis have esospermia.

They are infertile.

This is specifically due to the congenital bilateral absence of the vestephrines.

The tubes just degenerate during development because of the thick secretions.

It is a devastating multi -systemic disease driven by a single microscopic channel defect.

It really is the ultimate example of molecular pathology.

Let's move to a topic that is particularly haunting, especially for parents.

Sudden Intent Death Syndrome, or SIs.

SIDS is, by its very nature, a diagnosis of exclusion.

It is strictly defined as the sudden death of an infant under one year of age that remains completely unexplained after a thorough autopsy, a complete death scene investigation, and a full clinical history review.

So if you do an autopsy and find an undiagnosed congenital heart defect or overwhelming viral pneumonia, it is not SIDS.

Correct.

That would be classified as Sudden Unexpected Infant Death, or SCA.

SCA has a known cause once you look.

SIDS is the diagnosis we give when we exhaust every test and we still don't find the answer.

But there are prevailing theories.

The text deeply describes the triple risk model for SAIDs pathogenesis.

This is the best framework we have.

It proposes that SIDS occurs only when three specific overlapping factors intersect simultaneously.

Walk us through the three risks.

First, you have a vulnerable infant.

This means an infant who likely has a subtle underlying undetected biological defect.

The leading theory points to a delay in the development of the arousal and cardiorespiratory control centers in the brainstem, specifically the medullary serotonergic network.

So the biological alarm clock is broken.

The baby doesn't wake up or gasp when it functionally needs to.

Exactly.

If a normal baby gets too hot or re -breathes too much CO2 under a blanket, their brainstem forces them to wake up, turn their head, and cry.

A vulnerable infant's brainstem might fail to trigger that arousal reflex.

Okay, that's factor one.

What is the second?

A critical developmental period.

SIDS incidence dramatically peaks between one and six months of age.

Why that specific window?

Because biologically, this is when the infant's homeostatic controls are transitioning.

They are moving from primitive automatic neonatal reflexes to more mature integrated voluntary cortical control.

It is a highly unstable transitional time for the nervous system.

And the third factor,

the trigger.

An exogenous stressor.

This is almost always related to the sleeping environment.

Prone sleeping, meaning putting the baby on their stomach to sleep, or sleeping on a very soft surface that can trap exhaled CO2 around the face, or significant thermal stress like overdressing and overheating the baby.

This is exactly why the National Back to Sleep Campaign was so monumentally successful at reducing SIDS rates.

It entirely removed that third exogenous stressor.

Precisely.

You can't currently change the brainstem and you can't change the age, but you can change the sleeping position.

Morphologically, when a pathologist looks at a SACE case, does it look like anything specific?

The anatomical findings are notoriously subtle and mostly nonspecific.

The most consistently reported finding is multiple patechia, tiny pinpoint capillary hemorrhages.

Where are they found?

Usually on the thymus, the visceral and parietal pleura, and the epicardium of the heart.

And the text also mentions finding signs of extramedulary hematopoiesis in the liver.

Yes, or paraventricular leukomalacia in the brain.

These are subtle histological signs that suggest the infant was actually suffering from chronic, low -grade stress or episodic hypoxia for days or weeks prior to the sudden lethal event.

Meaning the death was sudden, but the underlying vulnerability was chronic.

Exactly.

We are entering the final leg of our deep dive through Chapter 10, tumors of infancy and childhood.

Cancer in pediatric populations is exceedingly rare compared to adults, thankfully.

But it is still the second leading cause of death in kids aged 5 to 14.

And the tumors themselves are biologically completely different from adult cancers.

Entirely different.

Adult cancers are overwhelmingly epithelial in origin.

Carcinomas of the lung, breast, colon, prostate, they take decades of environmental damage to develop.

Childhood cancers are usually mesenchymal or embryonal in origin.

They originate from primitive, actively growing tissues.

Yes, they are often designated by the suffix blastoma, like neuroblastoma or hepatoblastoma, because they histologically resemble the primitive embryonic tissues of those organs.

Furthermore, there's a very close relationship between abnormal development, or teratogenesis, and tumor formation in kids.

Before we get to the frank cancers, let's distinguish between two very common tumor -like lesions.

What is the pathological difference between a heterotopia and a homertoma?

A heterotopia, which is also called a choristoma, is microscopically normal tissue located in a completely abnormal anatomical location.

So the fels are fine, they just got lost during embryogenesis.

Right, like finding a perfectly formed little nodule of pancreatic tissue embedded in the submucosa of the stomach wall.

It's normal pancreas, just in the wrong zip code.

And a homertoma.

A homertoma is an overgrowth of disorganized tissue that is indigenous to the site.

It belongs there, but it grew into a chaotic mass.

Give it an example.

A homertoma in the lung might contain normal bronchial epithelium, normal cartilage, and normal blood vessels.

All those things belong in the lung.

But instead of forming a tube, they are just jumbled together in a solid disorganized tumor -like nodule.

Got it.

Now, moving to actual benign tumors.

Hemangiomas are by far the most common in infancy.

These are benign vascular tumors, the classic port wine stain or the raised strawberry hemangioma on the skin.

The truly fascinating thing about cavernous mangiomas in infants is their natural history.

They often regress spontaneously.

They do.

They can grow rapidly in the first few months, look very alarming, and then over a few years, they just undergo fibrosis and fade away completely without any surgical intervention.

Then we have teratomas.

These are germ cell tumors.

But in childhood, the most common anatomical location is highly specific.

Yes.

The sacrocosageal teratoma.

Figure 10 .22 in the text shows a massive protruding tumor at the very base of the infant's spine, right over the cosy kicks.

They can be incredibly large.

It can be larger than the infant's head.

Because teratomas are derived from totipotent cells, they contain mature or immature elements from all three germ layers,

ectoderm, mesoderm, and endoderm.

So you can find skin, hair, bone, cartilage, and gut epithelium all in the same mass.

You can.

Now, about 75 % of these are benign mature teratomas.

But their malignant potential depends almost entirely on the presence of immature tissue elements.

Specifically, if the pathologist finds immature neural tissue, like primitive neuroepithelium, it strongly indicates a much higher risk for malignant behavior.

Now, let's talk about the true malignant cancers.

Pathologists historically group many of these as the small round blue cell tumors.

Because under the microscope on an H &E stain, that is exactly what they look like.

Massive sheets of primitive, densely packed cells with huge blue hyperchromatic nuclei and barely any pink cytoplasm.

We will focus deeply on two absolute giants of pediatric pathology, neuroblastoma and Wilms tumor.

Let's start with neuroblastoma.

This is the most common extracranial solid tumor of childhood.

It arises from primordial neural crest cells.

So anatomically, where do you find them?

Anywhere along the sympathetic chain.

But the vast majority, about 40%, originate right inside the adrenal medulla.

The rest are found in the sympathetic ganglia of the abdomen, thorax or cervical region.

Clinically, a child usually presents with a large abdominal mass, maybe a fever and weight loss.

But because it's derived from sympathetic neural tissue, it's functionally active, isn't it?

Highly active.

About 90 % of neuroblastomas actively secrete catecholamines, epinephrine and norepinephrine.

So the infant might present with unexplained hypertension or flushing.

Exactly.

And diagnostically, we look for the breakdown metabolites of those catecholamines in the child's urine,

specifically VMA, vanillimandelic acid, and HVA, homo -vanillic acid.

Elevated urinary VMA and HVA are absolute classic markers for neuroblastoma.

Microscopically, beyond just small round blue cells, what specific structure is the pathologist looking for to confirm the diagnosis?

You are hunting for homo -right pseudorossettes.

Describe what that looks like.

Imagine a ring or a circle of those small blue tumor cells tightly surrounding a central space.

But the space isn't an empty lumen or a blood vessel.

The central space is filled with a tangled mass of very fine pink fibrillary material called neural pill.

It's basically the primitive tumor cells trying and failing to grow axons and dendrites.

That's exactly what it is.

It's an abortive attempt at neural differentiation.

Now, the prognosis of neuroblastoma is famously one of the most variable and complex in oncology.

It is remarkably stratified.

The two most critical determinants of prognosis are the age of the patient and the molecular genetics of the tumor.

Let's talk age first.

If the child is younger than 18 months at the time of diagnosis, the prognosis is generally excellent, even with some metastatic spread.

The tumors tend to respond well or even mature into benign ganglioneuromas.

But if the child is older than 18 months, the survival rate drops precipitously.

But there's a specific genetic marker that completely overrides the age factor.

Yes, NMYC amplification, usually written as MYCN.

MYCN is a powerful oncogene.

If the lab detects that the tumor cells have amplified, meaning multiple extra copies of the MYCN gene, it is automatically classified as a high risk, aggressively malignant tumor with a poor prognosis.

Regardless of how young the child is or what stage the tumor appears to be, NMYC is bad news.

It is the most important adverse genetic prognostic factor in neuroblastoma.

And then on the entirely opposite end of the spectrum, there's the incredibly mysterious stage 4S or stage MS, as it's almost called now.

Stage MS is genuinely one of the most fascinating phenomena in all of human biology.

It occurs exclusively in infants younger than 18 months.

The tumor originates in the adrenal gland, but it has aggressively metastasized to the skin, the liver, and the bone marrow.

Which in any adult cancer would be a terminal stage 4 diagnosis.

It sounds totally catastrophic.

The liver can be massively enlarged with metastatic nodules.

The skin can have these blue nodules scatter all over it, sometimes called blueberry muffin baby.

What actually happens?

In a massive percentage of these highly specific stage MS cases, the tumor simply regresses spontaneously.

With minimal or sometimes absolutely no chemotherapy, the tumor cells just die via widespread apoptosis, or they suddenly differentiate into mature, harmless nerve cells.

The metastatic disease literally vanishes.

It highlights how these pediatric tumors are sometimes driven more by temporary developmental timing errors than the permanent genetic chaos of adult cancers.

Finally, we need to cover the kidney.

Wilms tumor or nephroblastoma?

Wilms tumor is the most common primary renal tumor of childhood.

The peak age of incidence is a bit older than neuroblastoma, usually between two and five years old.

Describe the morphology.

What does it look like?

Grossly, as seen in figures 10 .26 and 10 .27, it presents as a massive solitary, well -circumscribed tan gray mass,

completely replacing normal kidney tissue.

And microscopically?

Microscopically, it is classically a triphasic tumor, meaning it contains three distinct cellular components all mixed together.

What are the three phases?

Number one, blastomal cells.

These are sheets of undifferentiated small round blue cells.

Number two, stromal cells.

This is connective tissue, often fibrocytic or macoys, but it can even show skeletal muscle differentiation.

And number three, epithelial cells.

What are the epithelial cells doing?

They are making abortive attempts to form renal tubules or primitive glomeruli.

So the tumor is essentially trying to organically build a completely new embryonic kidney inside the mass, but it's wildly uncoordinated.

That is exactly what is happening.

It perfectly mimics normal embryonic nephrogenesis just without the biological stop signals.

We also frequently find premalignant lesions called nephrogenic rests in the adjacent normal kidney tissue.

Wilm's tumor is also heavily associated with some very specific genetic syndromes.

Are most of them familial?

Actually, no.

Only about five to 10 % of Wilm's tumors involve inherited familial mutations.

Most are sporadic, but the ones that are syndromic are highly instructive about the molecular basis of the disease, usually involving the WT1 gene on promosom 11.

There are three main syndromes you need to know.

Let's start with Wadjeer syndrome.

Wadjeer is an acronym.

It stands for Wilm's tumor, aniridia, which is the complete absence of the colored iris in the eye, genital abnormalities like cryptorchidism, and retardation, referring to severe intellectual disability.

And what's the genetic defect?

It's caused by a massive germline dilution on chromosome 11P13 that physically deletes both the WT1 tumor suppressor gene and the adjacent PAC -X6 gene, which controls eye development.

Patients with Wadjeer have a 33 % chance of developing Wilm's tumor.

Second syndrome.

Denise Strash syndrome.

This presents with an extremely high risk of Wilm's tumor, around 90%.

Clinically, you see gonadal dysgenesis, meaning male pseudohermaphroditism, and early onset renal failure due to severe mesangial sclerosis in the glomeruli.

And the mutation.

This is a dominant negative missense mutation, specifically in the zinc finger DNA binding region of the WT1 gene itself.

It essentially jams the machinery.

And the third one has a very distinctive physical overgrowth presentation.

Beckwith -Weidman syndrome.

These children present with dramatic organomegaly, meaning massively enlarged organs like the liver and kidneys.

They have macroglossia, a very large protruding tongue,

omphalocell, and adrenoptitomegaly.

Is this one related to the WT1 gene too?

No, this one is different.

It is related to an imprinting defect in the WT2 locus, specifically involving the IGF2 gene, insulin -like growth factor 2.

Imprinting means the expression depends on which parent you inherited the allele from.

Right.

Normally, only the paternal copy of IGF2 is expressed.

But in Beckwith -Weidman, the maternal copy loses its imprinting and becomes actively expressed as well.

So you get a double dose of a potent growth factor.

Exactly.

And that massive overexpression of IGF2 drives the organomegaly and heavily predisposes the enlarged kidneys to developing Wilms tumor.

Well, we have covered an immense amount of dense pathological ground today.

From the very first cellular divisions of the embryo, through the specific physical and infectious perils of birth and prematurity, all the way to the truly unique genetic and embryonal cancers of childhood.

It is a profound journey through human development itself, seen through the lens of when things go wrong.

To wrap up, I want to leave everyone listening with a thought about that specific concept of regression we talked about.

We see it naturally in benign infantile hemangiomas.

But more incredibly, we see it in that stage MS neuroblastoma,

a metastatic cancer that just spontaneously cures itself.

It genuinely is one of the holy grails of modern cancer research.

It is, because these specific tumors in infants clearly have a biological switch, an inherent molecular mechanism that actively tells them to stop growing, to differentiate into mature tissue, or to simply die via apoptosis.

Right.

If researchers could figure out exactly what that switch is, how to therapeutically trigger that specific regression mechanism in a clinical setting, could we apply that to adult cancers?

Could we eventually teach an aggressive lung carcinoma or a metastatic breast cancer to just realize it's out of bounds and fade away?

It's a beautiful idea.

And it completely connects back to the very beginning of our deep dive.

Understanding the unique developing biology of the vulnerable child might just be the key to saving the adult.

A perfect place to stop.

Thank you for listening to this deep dive into chapter 10 of Robbins.

We sincerely hope you learned something new to take with you to the wards.

Always a pleasure.

A warm thank you from the Last Minute Lecture Team.

See you next time.